Loading company…
ReadCrysta provides MicroED and other structural biology services for drug research.
Founded in 2019 and based in Shenzhen, ReadCrysta develops Microcrystalline Electron Diffraction technology and an AI drug discovery platform. It provides structural biology and pharmaceutical solid-state research services for molecule and peptide analysis, vaccine design and enzyme engineering. Its capabilities include MicroED, cryo-electron microscopy and X-ray diffraction.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in